[Cimetidine versus combined therapy (antacid, anticholinergic drugs and oxyferriscorbone sodique) in short-term treatment of gastric and duodenal ulcer. A multicenter controlled trial (author's transl)].
D015083:2,3-Diketogulonic Acid / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000496:Alloxan / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D011897:Random Allocation; D013276:Stomach Ulcer / Q000188:drug therapy*; D013400:Sugar Acids / Q000627:therapeutic use*
D000863:Antacids; D004338:Drug Combinations; D006146:Guanidines; D010276:Parasympatholytics; D013400:Sugar Acids; D015083:2,3-Diketogulonic Acid; D000496:Alloxan; D002927:Cimetidine
Efficacité comparée de la cimétidine et d'un traitement associant antiacide, anticholinergique et cicatrisant dans la thérapeutique des ulcères gastriques et duodénaux en poussée évolutive. Résultats d'une étude contrôlée multicentrique.